Results 201 to 210 of about 103,719 (282)

Investigation of the pharmacological mechanisms of Denglao Qingguan decoction in inhibiting viral pneumonia through network pharmacology and in vitro laboratory validation. [PDF]

Front Med (Lausanne)
Lei B, Wang S, Li X, Chen F, Lu W, Liu B, Chen X, Chen R, Cui Z, Li A, Ren X, Yu L, Ma Q.   +12 more
europepmc   +1 more source

The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review. [PDF]

Int J Mol Sci
Malcangi G, Inchingolo AM, Casamassima L, Trilli I, Ferrante L, Longo M, Inchingolo F, Marinelli G, Palermo A, Dipalma G, Inchingolo AD.   +10 more
europepmc   +1 more source

Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study. [PDF]

J Inflamm Res
Gao B, Wang A, Zhang X, Zhang J, Ju Y, Zhao X, Wang W.   +6 more
europepmc   +1 more source

An Acute Case of Exogenous Lipoid Pneumonia Which Developed in Tent Sauna. [PDF]

Intern Med
Yamanaka M, Nishiyama Y, Fujishima N, Yokoyama A, Komiya K.   +4 more
europepmc   +1 more source

Bronchoalveolar Lavages Combined With Glucocorticoids in Management of Acute Exogenous Lipoid Pneumonia: 3 Case Reports. [PDF]

Case Rep Med
Huang X, Wu M, Xue Q, Yu G.
europepmc   +1 more source

Colistin-induced transition from non-mucoid to mucoid phenotype in resistant <i>Pseudomonas aeruginosa</i> ST3351. [PDF]

Virulence
Rosales-Reyes R, Flores-Vega VR, Ares MA, Wang G, Montelongo-Martínez LF, Varela-Nájera RG, de la Cruz MA, Paiva GE, Gudiño-Zayas ME, Hernández-Martínez G, Lincopan N, Cocotl-Yañez M, Pérez-López A, Rizo-Pica T, Lezana-Fernandez JL, Ortiz-Navarrete V, Partida-Sanchez S, Alcántar-Curiel MD, Valvano MA, Santos-Preciado JI.   +19 more
europepmc   +1 more source

Nanomaterials for the Treatment of Contamination by Nosocomial Pathogens in Intensive Care Units. [PDF]

Int J Nanomedicine
Chu YM, Zhang H, Huang Y, Li J, Huang M.
europepmc   +1 more source

Lactonic sophorolipids by <i>Saccharomyces cerevisiae</i>: production, characterization and their evaluation for combating clinically important microbial pathogens. [PDF]

RSC Adv
Al-Kashef AS, Alfifi KJ, Nooman MU, Khattab AEA, Helal MMI, Abdelraof M, Alruwaili FQ, Ghobashy MOI.   +7 more
europepmc   +1 more source

Treating Extensively Drug-Resistant Acinetobacter baumannii: Considerations for Host Characteristics and Type of Infections. [PDF]

Pathogens
Geladari A, Kouroupis D, Vafeidou K, Liakos V, Magoudi M, Papathanasiou AI, Iosifidis E, Roilides E, Antachopoulos C, Pyrpasopoulou A.   +9 more
europepmc   +1 more source